Bachem Holding AG
BANB
Rank in Stocks
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Share Price
$100.60
Market Cap
$7.54B
Change (1 day)
-1.49%
Change (1 year)
49.53%
Country
CH
Trade Bachem Holding AG (BANB)
Category
Healthcare
Stock split history for Bachem Holding AG (BANB)
Bachem Holding AG stock (symbol: BANB) underwent a total of 2 stock splits.
The most recent stock split occurred on May 05, 2022.
One BANB share bought prior to Jun 29, 2001 would equal to 100 BANB shares today.
The most recent stock split occurred on May 05, 2022.
One BANB share bought prior to Jun 29, 2001 would equal to 100 BANB shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| 2022-05-05 | 5:1 | x5 | x100 |
| 2001-06-29 | 20:1 | x20 | x20 |
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
